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http://dx.doi.org/10.1016/j.kjms.201Abstract No previous large-scale research has reported the association of chewing areca nut
(AN) with proteinuria. The aim of this study was to investigate such an association in men over
a 7-year study. In this cross-sectional research, we retrospectively reviewed the records of
health check-ups in a community hospital setting from 2003 to 2009. Laboratory tests, medical
histories, and the status of smoking cigarettes, drinking alcohol, and chewing AN were ob-
tained for each participant. Proteinuria was defined as having þ/e or heavier protein response
(including þ/e to 4þ) in a urine test performed by an automated chemical analyzer. We
compared characteristics in participants with and without proteinuria, and analyzed the
adjusted risk for proteinuria with chewing AN in middle-aged men. We also compared the
changes in adjusted risk for proteinuria under a stricter definition of proteinuria ( 1þ protein-
uria). There were 11,991 men with a mean age of 58.94  12.06 years. The prevalence of
proteinuria in AN chewers was 13.7%, and 11.2% for non-chewers (p Z 0.005). Of the 1381
participants with proteinuria, the proportion chewing AN was 15.3%, and 12.6% for those
without proteinuria (p Z 0.005). In the multivariate logistic regression analysis with three
different levels of adjustment models, with adjustment factors for age, drinking, smoking,
hypertension, diabetes, hyperlipidemia, body mass index, chronic kidney disease, anemia,
liver dysfunction, and hyperuricemia, the odds ratios of proteinuria for chewing AN were
1.61, 1.55 and 1.40 (all pZ 0.000). With the stricter definition of proteinuria, the odds ratiosof Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, 539 Zhong-Xiao Road,
m.tw (Y.-H. Hsu).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
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Areca nut and proteinuria in men 215became weaker (1.40, 1.36 and 1.19; pZ 0.009, 0.029 and 0.24). We concluded that chewing
AN was independently associated with risk of proteinuria in middle-aged Chinese men.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Proteinuria is an important manifestation of chronic kidney
disease (CKD). It has been accepted in many recent large
cohort studies as an independent risk factor for end-stage
renal disease, cardiovascular disease, ischemic stroke, and
also as an important prognostic factor in cardiovascular and
all-cause mortality [1e6]. Trace proteinuria is also a high-
risk condition for all-cause and cardiovascular mortality,
affecting 6e9% of the adult population [7], and can shorten
life span by up to 7 years [4]. In a study by Wen et al., the
magnitude of the increased risk due to trace proteinuria
was approximately equivalent to the risk from smoking
(1.70 vs. 1.55) [8].
Areca nut (AN) is the fourth most widely used addictive
substance in the world; it is estimated that 10e20% of the
world’s population chews AN in some form [9]. The preva-
lence of AN use has gradually increased in Taiwan, espe-
cially in rural areas and in adolescence [9]. In addition to
the associations with oral cancer [10], cardiovascular
disorders [11], cerebrovascular deaths [12], hyperglycemia
[13,14], obesity [15,16], metabolic syndrome [13], type 2
diabetes [14], liver cirrhosis [17], and CKD [18], AN chewing
has previously been associated with increased urinary
albumin excretion in patients with type 2 diabetes [19]. So
far, there has been no large scale research investigating the
association between chewing AN and proteinuria. In this
study, we conducted a retrospective study to evaluate the
association in middle-aged Chinese men.
Materials and methods
Participants
The National Health Insurance (NHI) Physical Check-up
Program (PCP) is a formally designed physical check-up
package for adults aged  40 years. It is issued by the
Bureau of National Health Insurance, Taiwan. The meth-
odology of the study is described in detail later [18]. A
brief report is as below. From 2003 to 2009, there were
a total of 15,836 men who attended the program in this
hospital, with 16,844 records in total; 637 of them atten-
ded the program more than once in different years with
a total of 1008 extra visits. All the participants were
included in this retrospective record review study. For
those participants who had more than one record, only the
health records from the first visit were included. Partici-
pants with incomplete data (n Z 3845) were excluded
from the analysis, and a total of 11,991 participants were
included. The project was approved by the Institutional
Review Board of this hospital.Methods
The NHI PCP contains a standard laboratory test package,
a brief questionnaire for basic demographic data (age, sex,
and address); health behaviors (status of smoking, drinking,
and chewing AN); personal medical history (including dia-
betes, hypertension, and hyperlipidemia); and a physical
examination (PE). The participants were asked to report
the three aforementioned health behaviors in the last 6
months as a non-user, social user, or regular user. PE data
include body height, body weight, systolic blood pressure
(SBP), and diastolic blood pressure (DBP), and body mass
index (BMI) was derived from the PE data. The standard
laboratory studies include serum creatinine (Scr), total
cholesterol (TC), triglyceride (TG), uric acid (UA), fasting
blood sugar (FBS), alanine aminotransferase (ALT), hemo-
globin (Hb), and urinalysis (including bio-chemical and
sediment microscopic examinations), which were all
measured with standard automated technology. In addi-
tion, we also calculated the estimated glomerular filtration
rate (eGFR) for all included participants using the Modifi-
cation of Diet in Renal Disease (MDRD) formula [20].
Participants fasted for 8 hours overnight before blood
sampling in the morning.Variable definition
CKD was defined as an eGFR <60 mL/min/1.73 m2 as calcu-
lated by the MDRD formula [20]. Certain major medical
diseases were defined according to domestic guidelines as
below. Hypertension (HTN) was defined as a past personal
history with or without medication or a blood pressure of at
least 140/90 mmHg [21]. Diabetes mellitus (DM) was defined
as a fasting plasma glucose level of  126 mg/dL or a history
of DM with or without medication [22]. Hyperlipidemia was
defined as a serum TC level  200 mg/dL, a TG level of 
200mg/dL, or a past personal history of high TC or TGwith or
without medication [23]. Hyperuricemia was defined as
serumUA level>7.0mg/dL according to domestic guidelines
[24]. Participantsweredefined as non-smokers if theydid not
smoke and as smokers if they smoked socially or regularly,
regardless of the amount they smoked. Participants were
defined as non-chewers if they never chewed AN and as
chewers if they chewed AN socially or regularly. Likewise,
participants were defined as non-drinkers if they did not
consume any alcohol and as drinkers if they consumed
alcohol socially or regularly. Proteinuria was defined as
having þ/e or heavier protein response (including þ/e to
4þ) in a urine dipstick test. Liver dysfunction was defined as
ALT>44 IU/L according to the upper limits of the automated
technology in this hospital.
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Biochemical tests including ALT, TC, TG, UA, and Scr were
measured by an automatic analyzer (Hitachi 7170; Hitachi
High Technologies Co., Tokyo, Japan). The test reagent for
ALT was manufactured by Roche Diagnostics GmbH (Man-
nheim, Germany), and the reagents for all other biochem-
ical tests were manufactured by Wako Pure Chemical
Industries Ltd. (Tokyo, Japan). Dipstick urinalysis was per-
formed by an automated chemical analyzer (URISYS 2400;
Roche Diagnostics).
Statistical analysis
Data were presented according to the status of being with
and without proteinuria, and were reported as means and
standard deviations or numbers and percentages, as
appropriate. Demographics, clinical characteristics, and
comorbidities were analyzed by Student t test for contin-
uous variables (all variables in Table 1), and by c2 test for
categorical variables (all variables in Table 2). Also, to
compare the included excluded groups, we conducted
certain analyses (Student t test for age, ManneWhitney U
test for DM, HTN, CKD and chewing AN) to establish if the
two groups were similar.
The prevalence of CKD increases with age, therefore, we
assessed the prevalence of proteinuria in the chewers and
non-chewers in different age groups (per decade until 70
years or older).
To determine the association between chewing AN and
proteinuria with different levels of adjustment, a multivar-
iate logistic regression model was used. We chose adjust-
ment factors based on the following rationale: (1) factors
that might influence proteinuria development, either
contributing to or protecting from; (2) potential confounding
factors for proteinuria; and (3) factors being both contrib-
uting factors and results of proteinuria. The chosen cova-
riates included age, smoking, BMI, drinking, HTN, DM,
hyperlipidemia, anemia, CKD, liver dysfunction, andTable 1 Demographic characteristics and laboratory profiles of
All patients
(n Z 11,991)
Age (y) 58.94  12.06
eGFR (mL/min/1.73 m2) 73.92  16.78
BMI (kg/m2) 25.11  3.47
Systolic BP (mmHg) 133.09  19.66
Diastolic BP (mmHg) 79.26  12.28
Creatinine (mg/dL) 1.15  0.35
Cholesterol (mg/dL) 206.55  41.34
Triglyceride (mg/dL) 156.67  166.08
Uric acid (mg/dL) 6.76  1.64
Fasting blood glucose (mg/dL) 107.08  40.46
ALT (IU/L) 37.02  42.73
Hemoglobin (g/dL) 15.16  1.47
Results are expressed as n (%) or means  standard deviation.
*p < 0.05; ***p < 0.001.
ALT Z alanine aminotransferase; BMI Z body mass index; BP Z bloohyperuricemia. We separated them into three levels, with
step 1 being age and chewing AN; step 2 adding smoking and
drinking; and step 3 adding the rest of the covariates.
To explore the association under stricter definitions of
proteinuria, we re-conducted the three-level MLRA using 
1þ proteinuria and compared the changes in odds ratio (OR)
with chewing AN.
We did four more subgroup analyses stratified by DM and
CKD status to establish the association of proteinuria with
chewing AN in certain important co-morbid states. All
analyses were carried out using SPSS for Windows version 18
(SPSS Inc., Chicago, IL, USA). A p < 0.05 was considered
statistically significant.
Results
There were a total of 11,991 men (mean age: 58.94  12.06
years) included in the analysis. Of all the participants, 1381
(16.4%) had proteinuria and 1545 (12.9%) were reported as
AN chewers. The prevalence of proteinuria in AN chewers
was 13.7% (211/1545), and 11.2% in non-chewers (1170/
10,446, p Z 0.005). In participants found to have protein-
uria, 15.3% (211/1381) were reported as chewers; in non-
proteinuric participants, 12.6% (1334/10,610) were
reported as chewers (p Z 0.005).
The demographic and biochemical laboratory data
analysis (Table 1) revealed that those who had proteinuria
tended to be older, have higher BMI, higher SBP and DBP,
higher Scr, and higher TC, TG, UA, FBS, and ALT, but lower
eGFR and Hb levels. In the analysis of personal habits and
comorbidities (Table 2) those who had proteinuria tended
to have higher prevalence of CKD, smoking, AN chewing,
DM, HTN, hyperlipidemia, liver dysfunction, anemia, and
hyperuricemia, but there was a lower proportion of
drinkers. As for the comparison of the included and
excluded groups (Table 3), it seemed that the excluded
group was more likely to be older and have CKD, but less
likely to have HTN. Both groups were similar for DM and
chewing AN.the 11,991 participants stratified by status of proteinuria.
Proteinuria (e) Proteinuria (þ)
(n Z 10,610, 88.5%) (n Z 1381, 16.4%)
58.41  11.96 63.00  12.08***
75.13  15.84 64.62  20.40***
25.04  3.40 25.67  3.95***
131.93  18.94 142.00  22.57***
78.80  11.88 82.74  14.56***
1.12  0.23 1.38  0.77***
206.14  40.01 209.66  50.26*
152.26  153.27 190.54  240.35***
6.72  1.59 7.13  1.92***
104.31  35.48 128.34  63.53***
36.56  42.19 40.56  46.54***
15.19  1.40 14.97  1.92***
d pressure; eGFR: estimated glomerular filtration.
Table 2 Personal behaviors and comorbidities of the 11,991 participants stratified by status of proteinuria.
All patients Proteinuria (e) Proteinuria (þ)
(n Z 11,991) (n Z 10,610) (n Z 1381)
CKD 2165 (18.1%) 1638 (15.4) 527 (38.2)***
Smoker 4448 (37.1%) 3902 (36.8%) 546 (39.5%)*
Drinker 3892 (32.5%) 3485 (32.8%) 407 (29.5%)*
Areca nut chewer 1545 (12.9%) 1334 (12.6%) 211 (15.3%)**
Diabetes 1794 (15.0%) 1309 (12.3%) 485 (35.1%)***
Hypertension 5437 (45.3%) 4532 (42.7%) 905 (65.5%)***
Hyperlipidemia 437 (3.6%) 371 (3.5%) 66 (4.8%)*
Liver dysfunction 2484 (20.7%) 2145 (20.2%) 339 (24.5%)***
Anemia 784 (6.5%) 607 (5.7%) 177 (12.8%)***
Hyperuricemia 4702 (39.2%) 4045 (38.1%) 657 (47.6%)***
Results are expressed as n (%).
*p < 0.05; ** p < 0.01; *** p < 0.001. CKD Z chronic kidney disease.
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non-chewers in different age groups (per decade until  70
years old), as shown in Fig. 1, revealed that the prevalence
of proteinuria increased with age in the whole group, the
chewing group, and the nonchewing group. The prevalence
of proteinuria was significantly higher in chewers in the two
younger age groups (40 ( 50 and 50 ( 60 years), but not
significantly different in the two elder age groups (60( 70
and 70 years).
In the three-step model MLRA with adjustment factors
described earlier, chewing AN was a consistent and inde-
pendent risk factor for proteinuria throughout the three
different levels of adjustment (Table 4, OR was 1.61, 1.55
and 1.40 for models 1, 2 and 3, respectively, all pZ 0.000);
however, when a stricter definition of proteinuria ( 1þ)
was applied, the case number of proteinuria decreased
from 1381 to 574, and the associations became weaker (OR:
1.40, 1.36 and 1.19; pZ 0.009, 0.029 and 0.240 for models
1, 2 and 3, respectively).
In the subgroup analyses (Fig. 2), the risk of proteinuria
with chewing AN was not significant in the diabetes group
[OR: 1.33, 95% confidence interval (CI): 0.96e1.84,
p Z 0.084] and was significantly higher in the collective
group (OR: 1.40, 95% CI: 1.17e1.68, p Z 0.000), non-
diabetes group (OR: 1.41, 95% CI: 1.13e1.76, p Z 0.002),
and non-CKD group (OR: 1.46, 95% CI: 1.19e1.80,
p Z 0.000). The association in the CKD group was nonsig-
nificant (OR: 1.13, 95% CI: 0.78e2.02, p Z 0.522).Table 3 Comparison of the main characteristics of the include
Included participants (n Z 11,991)
Age (y) 58.94  12.06
Diabetes 1794 (15.0%)
Hypertension 5437 (45.3%)
CKD 2165 (18.1%)
Areca nut 1545 (12.9%)
CKD Z chronic kidney disease.Discussion
The data in the current research support chewing AN as
being independently associated with the risk of proteinuria
in men with the following findings. First, AN chewers had
a significantly higher prevalence of proteinuria than non-
chewers, both collectively and in certain different age
groups. Second, the participants who were found to have
proteinuria also had a significantly higher proportion of AN
use than those who had no proteinuria. Third, chewing AN
was independently associated with increased odds of
proteinuria after adjustments for age, drinking, smoking,
HTN, DM, hyperlipidemia, BMI, CKD, anemia, liver
dysfunction, and hyperuricemia.
AN has been a popular part of life in several regions
including Southern Asia, Southeastern Asia, and the
AsiaePacific region for a long time. There is great variation
in ways of preparation [25] and the main pathogenic
ingredients and mechanism are yet to be determined.
There are several possible mechanisms by which chewing
AN might cause proteinuria. To start, in vitro studies have
revealed that AN components increase the release of
inflammatory mediators including prostanoids, interleukin-
6, interleukin-8, and tumor necrosis factor-a [26,27]. An
increased inflammatory status is associated with increased
urinary albumin excretion in type 2 diabetes and the non-
diabetic population [28]. Also, arecoline, an active ingre-
dient of AN, can decrease vascular tone. Higher doses ofd participants with the excluded ones.
Excluded participants (n Z 3845) p value
60.53  13.09 <0.001
315 (19.6%) 0.558
532 (33.1%) <0.001
367 (23.0%) <0.001
234 (15.1%) 0.921
Figure 1. Comparison of proteinuria prevalence in areca nut
chewers versus non-chewers, stratified by age.
Figure 2. Odds ratio of proteinuria with areca nut chewing
stratified by status of diabetes and chronic kidney disease.
218 W.-H. Liu et al.arecoline inhibit endothelial cell growth, which suggests
that long-term AN use might induce endothelial dysfunction
and associated diseases [29]. Chewing AN has a central
sympathetic effect resulting in an accelerated heart rate
and an increased blood flow [30], which might in turn lead
to increased proteinuria. In addition, AN extract might
cause breaks in kidney cell DNA in an animal model [31].
Participants who chew AN also have a higher proportion of
smokers [18], which is itself a traditional CKD risk factor. It
is possible that the effect of chewing AN on proteinuria in
fact arises from the effect of smoking. However, as shown
in Table 4, chewing AN has an independently stronger
association with proteinuria than smoking.
Trace proteinuria by urine dipstick is a powerful
predictor of mortality risk and CKD [32]. Methodologically,
urine dipsticks are read either visually or by automated
instruments. The inconsistent and poor results from visual
readings have left clinicians the impression that a trace
proteinuria report is unreliable and often regarded as
negative [33e36]. Automated dipstick reading, the method
we used in this study, provided optimal consistency,
showing a higher proportion of trace proteinuria results.
These trace findings occurred 6e7 times more frequently
than results of 1þ or more [4,32,37,38]. White et al. have
conducted a diagnostic performance test and reported
a dipstick test result <1þ or less than trace has a highly
negative predictive value in the general community setting,
and reduces to minimal the risk to miss a diagnosis ofTable 4 Multivariate logistic regression analyses for post-adjus
Age adjusted
OR (CI) (Model 1)
Age and pe
adjusted OR
Age 1.04 (1.03e1.04) *** 1.04 (1.0
Areca nut chewing 1.61 (1.37e1.90) *** 1.55 (1.3
Smoking e 1.20 (1.0
Drinking e 0.94 (0.8
Body mass index e e
Hypertension e e
Diabetes e e
Hyperlipidemia e e
CKD e e
** p < 0.01; *** p < 0.001.
CKD Z chronic kidney disease.
a Also post-adjustment with anemia, liver dysfunction and hyperurimacroalbuminuria [39]. With such understanding, clinicians
may have a correct response seeing a positive urine dipstick
test (with further laboratory confirmation), and urine
dipstick remains a proper tool for screening in the general
population [40]. In the current study, however, when we
chose a stricter definition of proteinuria ( 1þ), the
significance of association in Model 3 was not sustained,
although the risk was still higher for AN chewers. We
believe this to be related to the greatly reduced case
number. Further research with larger case numbers of
proteinuria should be conducted.
Our data demonstrated that age had an important
influence on the association of chewing AN with protein-
uria, as shown in Table 4 and Fig. 1. Elderly people who still
chew AN have much higher cardiovascular and renal risks
and should be seriously followed up due to the following
factors. First, age itself is a risk factor for proteinuria.
Second, as reported by Tseng et al. in older age groups,
a protective behavioral pattern is dominant [41], implying
that as age increases, people tend to change their personal
habits in a more protective way, and no longer chew AN or
smoke. Third, in AN chewers there is a high probability of
concurrent smoking and drinking [18,42]. This group should
be targeted for more health care intervention and health
education for early abstinence.
In patients with diabetes or CKD, the association of
chewing ANwith proteinuria deserves further observation. Intment proteinuria odds in different models.
rsonal habits
(CI) (Model 2)
Age, personal habits and
comorbidity adjusted OR (CI) (Model 3)a
3e1.04) *** 1.02 (1.01e1.02) ***
0e1.84) *** 1.40 (1.17e1.68) ***
6e1.35) ** 1.22 (1.08e1.39) **
2e1.08) 0.99 (0.86e1.14)
1.03 (1.02e1.05) ***
1.77 (1.56e2.02) ***
3.29 (2.88e3.76) ***
0.88 (0.66e1.18)
2.42 (2.10e2.80) ***
cemia.
Areca nut and proteinuria in men 219participants with DM, the association of chewing AN with
proteinuria was marginally significant (OR: 1.33, 95% CI:
0.96e1.84, p Z 0.084), similar to the previous analysis
by Tseng, who reported the multivariate-adjusted OR for
albuminuria in chewers versus non-chewers was 2.02 (95% CI:
1.13e3.63) [19]. For comparison,we believe the importance
of the current research to lie within: the fact that we
included more adjustment factors in our study (liver
dysfunction, hyperuricemia, anemia, and alcohol drinking);
as shown in the three-step model in Table 3, when more
adjustment factors were included, the OR value became
lower; this study had a larger case number (11,991 partici-
pants, 1545 chewers versus 572 participants, 65 chewers)
which might provide stronger evidence. Also, CKD is consid-
ered to result from kidney disease progression after
proteinuria. It is acceptable that with CKD, chewing AN does
not exert further influence on the risk of proteinuria.
In the stratification analyses with status of CKD and DM
(Fig. 2), our data demonstrated a “conditional” association
of chewing AN with proteinuria in non-diabetic or non-CKD
conditions, similar to previous reports [18]. The association
of chewing AN with proteinuria was persistent in all three
models of analysis, in non-diabetic and non-CKD groups.
The ORs in these groups were similar (1.40e1.42 overall,
1.33 in diabetes, 1.41 in non-diabetes, and 1.46 in the non-
CKD group), implying that under simple physiological
conditions, the effect of chewing AN looks consistent.
Our data demonstrated that the OR of proteinuria with
chewing AN was higher than that of smoking and drinking.
Chewing AN was seldom considered a traditional risk factor
of proteinuria in the past. Taking all these findings
together, it is time to pay more attention to this issue.
Further cohort investigations to delineate the temporal
changes and doseeresponse effect with chewing AN should
be considered, and AN abstinence becomes more mean-
ingful. We strongly recommend that the authorities grant
more resources to this issue.
There were several limitations to this study. This was
a retrospective cross-sectional study based on the results
of a health check-up program in a single hospital setting.
Sampling and ascertainment bias might have arisen from
several aspects. First, the laboratory data were collected
with only one-time urine sample and blood tests, which
was vulnerable to variation and might not have repre-
sented true physiological situations. Second, the partici-
pants who took the initiative to undergo the health check-
up in this hospital might have had a higher health alert,
higher socioeconomic position, or already had certain
ailments and might not be representative of the general
population. Third, the comparison from Table 3 reminds us
that some of the participants of older age, with more CKD
yet less HTN were not included, which might have incurred
a certain sampling bias and should be considered in
interpreting the results. Another limitation was that the
questionnaire on health behavior did not include
a detailed quantitative assessment (duration and amount)
of AN use, nor did it include previous abstinence history.
Under such circumstances, a substantial temporal rela-
tionship and quantitative doseeresponse effect cannot be
concluded.
In conclusion, our study showed that chewing AN was
independently associatedwith the risk of proteinuria inmen.The association was consistently present under different
levels of adjustment analyses. Further research is warranted
to delineate the doseeresponse effect and temporal rela-
tionship between chewing AN and proteinuria.
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